Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 108035-45-6 | MDL No. : | MFCD00456057 |
Formula : | C10H8N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YJCYHGYOXHANSY-UHFFFAOYSA-N |
M.W : | 188.18 | Pubchem ID : | 1475901 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 50.98 |
TPSA : | 65.98 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.56 cm/s |
Log Po/w (iLOGP) : | 0.97 |
Log Po/w (XLOGP3) : | 1.25 |
Log Po/w (WLOGP) : | 1.77 |
Log Po/w (MLOGP) : | 0.9 |
Log Po/w (SILICOS-IT) : | 1.92 |
Consensus Log Po/w : | 1.36 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.24 |
Solubility : | 1.07 mg/ml ; 0.00571 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.23 |
Solubility : | 1.1 mg/ml ; 0.00584 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.13 |
Solubility : | 0.14 mg/ml ; 0.000745 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.35 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With hydrogenchloride In ammonium hydroxide; water | Step 1: 4-(1H-Imidazol-2-yl)-benzoic Acid (248) To a stirred solution of 4-formylbenzoic acid (2.00 g, 12.3 mmol) in ammonium hydroxide (9 ml) was added glyoxal (2.86 ml, 20.0 mmol). The reaction mixture was stirred 16 h at room temperature. 1N HCl was added to the reaction mixture to acidify to pH 5. The solvent was evaporated and the residue was triturated 30 min. in water (20 ml) and filtered to obtain the title compound 248 (2.08 g, 83percent) as a white solid. LRMS: 188.1 (Calc.); 189.1 (found). |
83% | With hydrogenchloride In ammonium hydroxide; water | Step 1: 4-(1H-Imidazol-2-yl)-benzoic acid (248) To a stirred solution of 4-formylbenzoic acid (2.00 g, 12.3 mmol) in ammonium hydroxide (9 ml) was added glyoxal (2.86 ml, 20.0 mmol). The reaction mixture was stirred 16 h at room temperature. 1N HCl was added to the reaction mixture to acidify to pH 5. The solvent was evaporated and the residue was triturated 30 min. in water (20 ml) and filtered to obtain the title compound 248 (2.08 g, 83percent) as a white solid. LRMS: 188.1 (Calc.); 189.1 (found). |
83% | With hydrogenchloride In ammonium hydroxide; water | Step 1: 4-(1H-Imidazol-2-yl)-benzoic acid (248) To a stirred solution of 4-formylbenzoic acid (2.00 g, 12.3 mmol) in ammonium hydroxide (9 ml) was added glyoxal (2.86 ml, 20.0 mmol). The reaction mixture was stirred 16 h at room temperature. 1N HCl was added to the reaction mixture to acidify to pH 5. The solvent was evaporated and the residue was triturated 30 min. in water (20 ml) and filtered to obtain the title compound 248 (2.08 g, 83percent) as a white solid. LRMS: 188.1 (Calc.). 189.1 (found). |
[ 883543-82-6 ]
2-((1H-Imidazol-1-yl)methyl)benzoic acid
Similarity: 0.77
[ 159589-71-6 ]
2-(2-Methyl-1H-imidazol-1-yl)benzoic acid
Similarity: 0.76
[ 1088994-22-2 ]
5-Methyl-2-(pyrimidin-2-yl)benzoicacid
Similarity: 0.75
[ 479553-01-0 ]
1H-Pyrrolo[2,3-b]pyridine-4-carboxylic acid
Similarity: 0.84
[ 754214-42-1 ]
1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid
Similarity: 0.80
[ 133427-08-4 ]
Imidazo[1,2-a]pyridine-8-carboxylic acid
Similarity: 0.79
[ 139022-25-6 ]
Imidazo[1,2-a]pyridine-6-carboxylic acid
Similarity: 0.78
[ 872355-55-0 ]
6-Methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid
Similarity: 0.77
[ 883543-82-6 ]
2-((1H-Imidazol-1-yl)methyl)benzoic acid
Similarity: 0.77
[ 159589-71-6 ]
2-(2-Methyl-1H-imidazol-1-yl)benzoic acid
Similarity: 0.76
[ 216955-75-8 ]
6-(1H-Imidazol-1-yl)nicotinic acid
Similarity: 0.76